These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 17583516)

  • 1. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
    de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
    Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization, phase solubility and molecular modeling of alpha-cyclodextrin/pyrimethamine inclusion complex.
    de Araujo MV; Macedo OF; Nascimento Cda C; Conegero LS; Barreto LS; Almeida LE; da Costa NB; Gimenez IF
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Feb; 72(1):165-70. PubMed ID: 19019728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
    Yang B; Lin J; Chen Y; Liu Y
    Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on 6-chloro-5-(1-naphthyloxy)-2-(trifluoromethyl)-1H-benzimidazole/2-hydroxypropyl-β-cyclodextrin association: Characterization, molecular modeling studies, and in vivo anthelminthic activity.
    Rojas-Aguirre Y; Yépez-Mulia L; Castillo I; López-Vallejo F; Soria-Arteche O; Hernández-Campos A; Castillo R; Hernández-Luis F
    Bioorg Med Chem; 2011 Jan; 19(2):789-97. PubMed ID: 21190860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
    Yap KL; Liu X; Thenmozhiyal JC; Ho PC
    Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-beta-cyclodextrin.
    Zhang M; Li J; Zhang L; Chao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1891-5. PubMed ID: 18722807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion complex of trimethoprim with beta-cyclodextrin.
    Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR characterization of the host-guest inclusion complex between beta-cyclodextrin and doxepin.
    Cruz JR; Becker BA; Morris KF; Larive CK
    Magn Reson Chem; 2008 Sep; 46(9):838-45. PubMed ID: 18615634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization, phase-solubility, and molecular modeling of inclusion complex of 5-nitroindazole derivative with cyclodextrins.
    Jullian C; Morales-Montecinos J; Zapata-Torres G; Aguilera B; Rodriguez J; Arán V; Olea-Azar C
    Bioorg Med Chem; 2008 May; 16(9):5078-84. PubMed ID: 18375132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
    Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
    Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
    de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
    Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.
    Palmieri GF; Wehrlé P; Martelli S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):653-60. PubMed ID: 9876510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion complexes of bisphenol A with cyclomaltoheptaose (beta-cyclodextrin): solubilization and structure.
    Yang ZX; Chen Y; Liu Y
    Carbohydr Res; 2008 Sep; 343(14):2439-42. PubMed ID: 18653172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.